Skip to main content

ICON-9: A phase 3 randomised trial of cediranib and olaparib maintenance in patients with relapsed platinum sensitive ovarian cancer

Project Member(s): Viney, R., De Abreu Lourenco, R., Vargas Parada, C.

Funding or Partner Organisation: Cancer Australia (Priority-driven Collaborative Cancer Research Scheme)
Cancer Australia (Priority-driven Collaborative Cancer Research Scheme)

Start year: 2018

FOR Codes: Health Economics, Evaluation of Health Outcomes, Health Policy Economic Outcomes